Estados Unidos · Bolsa y Finanzas · Quartz

Roche struck a cancer drug licensing deal with China's Hansoh that could exceed $15 billion

Publicado por Quartz · Estados Unidos hace 1 h

Hansoh will receive $400 million upfront and keep rights to the programs in mainland China, Hong Kong, Macau and Taiwan

Leer el artículo completo en Quartz Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (qz.com)

También te puede interesar

Boomers are buying into the promise of monthly income from options ETFs, but there's a tax catch

Apple updates guidelines to ban nudify apps masquerading as regular apps to pass review

Total Energy plans share buyback

Business Insider

Barbara Palvin says she doesn't want praise for walking the Victoria's Secret fashion show 6 weeks postpartum

Elon Musk Says He Will Give a SpaceX Share to ‘Every Kid in America’

Morning Minute: Crypto Rebounds as 'Black Monday' Looms